{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:04:30Z","timestamp":1792746270526,"version":"4.5.0"},"reference-count":35,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>D-dimer assessment has several established roles in venous thromboembolism (VTE) and disseminated intravascular coagulation diagnosis, and recently the risk stratification of coronavirus disease 2019 (COVID-19). D-dimer assays are neither standardized nor harmonized, use varying methodologies, and use different reporting units, all resulting in a lack of interchangeability and generalizability of assays. Using large multiyear datasets from an international laboratory quality assurance program, we assessed (1) common D-dimer assays in use worldwide, (2) differences in analytical performance between different methods, and (3) interlaboratory variability between positive samples. External proficiency testing results from laboratories participating in the External Quality Control for Assays and Tests (ECAT) Foundation were analyzed from 2017 to 2023. Annually, between 578 and 690 laboratories participated in the D-dimer sample surveys with response rates ranging from 88 to 97%. The three most common assays in use in 2023 were the Siemens Innovance D-dimer (42%), the IL HemosIL D-dimer HS 500 (20%), and the Diagnostica Stago (Stago) Liatest D-dimer Plus (10%)\u2014all these are automated, quantitative, latex immunoassays expressed in fibrinogen equivalent units (FEU). The highest interlaboratory variability was observed around the typical VTE exclusion threshold of 0.5\u2009mg\/L FEU. Lower interlaboratory variability was observed at values above 0.8\u2009mg\/L FEU. Our study provides recent, international performance data on currently used D-dimer assays and describes the significant variability between assays and across D-dimer concentrations. We demonstrate that assays are not interchangeable and that using them interchangeably has the potential to result in clinically important errors. There is an urgent need to educate users about these issues and to work towards harmonizing D-dimer units and reporting.<\/jats:p>","DOI":"10.1055\/s-0044-1791700","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T18:44:47Z","timestamp":1729190687000},"page":"641-650","source":"Crossref","is-referenced-by-count":9,"title":["D-dimer\u2014An International Assessment of the Quality of Laboratory Testing: Implications for D-dimer Use in the Real World"],"prefix":"10.1055","volume":"51","author":[{"given":"Carolyne","family":"Elbaz","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine J.","family":"Hollestelle","sequence":"additional","affiliation":[{"name":"External Quality Control for Assays and Tests (ECAT) Foundation, Voorschoten, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Meijer","sequence":"additional","affiliation":[{"name":"External Quality Control for Assays and Tests (ECAT) Foundation, Voorschoten, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Liederman","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Selby","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"issue":"S 01","key":"ref1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/ijlh.12665","article-title":"Review of D-dimer testing: good, bad, and ugly","volume":"39","author":"L A Linkins","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"07","key":"ref2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ajh.25482","article-title":"The D-dimer assay","volume":"94","author":"E D Johnson","year":"2019","journal-title":"Am J Hematol"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/M14-1275","article-title":"D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study","volume":"162","author":"C Kearon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.2014.2135","article-title":"Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study","volume":"311","author":"M Righini","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1160\/TH17-03-0182","article-title":"Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism","volume":"117","author":"S Takach Lapner","year":"2017","journal-title":"Thromb Haemost"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"j1065","DOI":"10.1136\/bmj.j1065","article-title":"Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study","volume":"356","author":"M A Rodger","year":"2017","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"l4363","DOI":"10.1136\/bmj.l4363","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"F Khan","year":"2019","journal-title":"BMJ"},{"issue":"07","key":"ref8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-149-7-200810070-00008","article-title":"Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism","volume":"149","author":"M Verhovsek","year":"2008","journal-title":"Ann Intern Med"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/01.CCM.0000147769.07699.E3","article-title":"Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation","volume":"32","author":"K Bakhtiari","year":"2004","journal-title":"Crit Care Med"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"H Al-Samkari","year":"2020","journal-title":"Blood"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.thromres.2005.08.006","article-title":"D-dimer assays: the current status and new assay technologies","volume":"118","author":"C E Dempfle","year":"2006","journal-title":"Thromb Res"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1160\/TH05-01-0042","article-title":"A model for the harmonisation of test results of different quantitative D-dimer methods","volume":"95","author":"P Meijer","year":"2006","journal-title":"Thromb Haemost"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.thromres.2015.11.031","article-title":"Harmonisation of D-dimer - a call for action","volume":"137","author":"C Longstaff","year":"2016","journal-title":"Thromb Res"},{"issue":"09","key":"ref14","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/jth.14956","article-title":"The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis","volume":"18","author":"J Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/ijlh.12318","article-title":"Stability of coagulation proteins in lyophilized plasma","volume":"37","author":"I Jennings","year":"2015","journal-title":"Int J Lab Hematol"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1538-7836.2007.02328.x","article-title":"Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review","volume":"5","author":"M Di Nisio","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1160\/TH-08-10-0689","article-title":"VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies","volume":"101","author":"M Carrier","year":"2009","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1055\/s-2006-951296","article-title":"Different accuracies of rapid enzyme-linked immunosorbent, turbidimetric, and agglutination D-dimer assays for thrombosis exclusion: impact on diagnostic work-ups of outpatients with suspected deep vein thrombosis and pulmonary embolism","volume":"32","author":"J J Michiels","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"03","key":"ref21","first-page":"505","article-title":"A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism","volume":"100","author":"P de Moerloose","year":"2008","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/MBC.0b013e32830f1bae","article-title":"Performance of the automated and rapid HemosIL D-Dimer HS on the ACL TOP analyzer","volume":"19","author":"G L Salvagno","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.thromres.2021.02.003","article-title":"Diagnostic accuracy of four different D-dimer assays: a post-hoc analysis of the YEARS study","volume":"201","author":"H M Hamer","year":"2021","journal-title":"Thromb Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.thromres.2018.07.020","article-title":"\u201cHERDOO2\u201d clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?","volume":"169","author":"M A Rodger","year":"2018","journal-title":"Thromb Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1781450","article-title":"Variable performance of D-Dimer testing: the Australasian\/Asia-Pacific experience","author":"E J Favaloro","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2310\/8000.2013.130986","article-title":"Combination pretest probability assessment and D-dimer did not reduce outpatient imaging for venous thromboembolism in a tertiary care hospital emergency department","volume":"16","author":"S Ingber","year":"2014","journal-title":"CJEM"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.pathol.2020.08.010","article-title":"Variability in D-dimer reporting revisited","volume":"53","author":"E J Favaloro","year":"2021","journal-title":"Pathology"},{"issue":"S 01","key":"ref28","first-page":"83","article-title":"Performance of quantitative D-dimer assays in the ECAT external quality assessment programme","volume":"14","author":"P Meijer","year":"2000","journal-title":"Fibrinolysis Proteol"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1538-7836.2006.02252.x","article-title":"Performance of quantitative D-dimer methods: results of the Italian external quality assessment scheme","volume":"5","author":"A Tripodi","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.mbc.0000179912.80656.2b","article-title":"The performance of quantitative D-dimer assays in laboratory routine","volume":"16","author":"M Spannagl","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"08","key":"ref31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.5858\/arpa.2012-0296-CP","article-title":"D-dimer: simple test, tough problems","volume":"137","author":"J D Olson","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"n2400","DOI":"10.1136\/bmj.n2400","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"M Sholzberg","year":"2021","journal-title":"BMJ"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"R D Lopes","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: The HEP-COVID randomized clinical trial","volume":"181","author":"A C Spyropoulos","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"09","key":"ref35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with Covid-19","volume":"385","author":"E C Goligher","year":"2021","journal-title":"N Engl J Med"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-0040-1709650","article-title":"D-dimer is associated with severity of coronavirus disease 2019 (COVID- 19): a pooled analysis","volume":"120","author":"G Lippi","year":"2020","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11239-021-02527-y","article-title":"Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study)","volume":"53","author":"L Garc\u00eda de Guadiana-Romualdo","year":"2022","journal-title":"J Thromb Thrombolysis"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1791700.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T23:42:10Z","timestamp":1755214930000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1791700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":35,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2025,8,8]]},"published-print":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1791700","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]}}}